Trial intelligence / Profile preview

Augmentation of Interpersonal Psychotherapy (IPT) with D-cycloserine

DRKS00007910Phase 2Withdrawn

Sponsor
Universitätsklinikum Freiburg
Start
Jun 2016
Modality
Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in major depressive disorder (MDD) comparing D-cycloserine + IPT with Placebo + IPT (2 arms). Planned start Jun 2016; status: withdrawn.

02

Drugs

d-cycloserine
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on DRKS00007910.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on DRKS00007910.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call